| Code | 4284E | ||||||||||
| MA number | 24/0198/23-S | ||||||||||
| Product Form: | tbl 40x20 mg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 24 - ANTIHISTAMINICA, HISTAMIN | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.08.2023 |
| Validity: | 24.08.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Abisax 20 mg_08_2023.rtf
|
| PIL: |
PIL_Abixax 20 mg_08_2023_OTC.pdf
|
| PIL: |
PIL_Abixax 20 mg_08_2023_Rx.pdf
|
| Safety feature | Yes |
| Data update: | 14.11.2023 |
